Table 1.

Features of patients and clinical presentation

Patient	Age/sex	Symptoms	Coexisting conditions	Chest radiograph; treatment	Altered blood laboratory findings	Time of death from onset of symptoms	Postmortem tissues
R	77/F	-Shortness of breath -Dyspnea -Cough -Fatigue -Fever	-Ischemic cardiomyopathy -Hypertension -Type II diabetes mellitus -NASH1 -Dementia -NHC/B2	-BGGO3 -Kaletra4, chloroquine, Ceftriaxone	Increased creatinine levels, proteinemia, albuminemia	18 days	Trachea Lung, Kidney, Liver
J	70/M	-Dyspnea -Fever	-Ischemic cardiomyopathy -Hypertension -Coronary artery disease -Dementia -NHC/B	-BGGO -Kaletra, interferon alfa-2b, Azithromycin	Increased creatinine levels	15 days	Lung, Kidney
D	85/M	-Dyspnea -Fever	-Coronary artery disease -Hypertension -Dementia -NHC/B	-BGGO --Kaletra, interferon alfa-2b, Azithromycin	Increased creatinine levels	15 days	Lung, Kidney
B	68/F	-Shortness of breath -Dyspnea -Cough	-Coronary artery disease -Asthma -Obesity -NASH - Hypertension -NHC/B	-BGGO -Kaletra, interferon alfa-2b, Azithromycin	Increased creatinine levels, proteinemia, albuminemia, Increased liver damage markers	13 days	Lung, Kidney, Liver
T	80/F	-Dyspnea -Cough -Fatigue	-Coronary artery disease -Hypertension	-BGGO -Kaletra, interferon alfa-2b, Azithromycin		15 days	Lung
C (No COVID)	75/M		-Chronic obstructive pulmonary disease -Hypertension -Coronary artery disease		-	-	Lung

¹Nonalcoholic steatohepatitis

²No history of HCV/HBV infection

³Bilateral ground glass opacity

⁴Lopinavir, ritonavir